(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
LATEST POSTS
- 1
This ‘CSI: Miami’ star spent years solving crimes on TV. Then she became the target of one herself. - 2Australians told to continue Easter travel plans despite fuel shortages
- 3Rediscovering Experience Through Excursions: Individual Travel Stories
- 4Proficient Cultivating Devices for a Lovely and Useful Nursery in 2024
- 5Americans generally like wolves − except when we’re reminded of our politics
- Current Chateaus: Advancement and Style
- SpaceX launches Starlink satellites on its 150th Falcon 9 mission of the year
- Mexico says a third of 130,000 missing people might be alive, fueling criticisms by families
- Step by step instructions to Protect Your Speculations with Cd Rates
- How a toxic self-improvement trend with a funny name took over your feed
- Scientists find twisting magnetic waves on the sun. Could this help solve a huge solar mystery?
- They died 'doing what they loved': The stories of workers in their 80s who died on the job
- 6 Pet Sitting Administrations for Your Cherished Pets
- Figure out how to Put resources into Lab Precious stones: A Novice's Aide
